ArticleBJUI compass2022

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration-resistant prostate cancer: AFTERCAB study.

Hiroji Uemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.